Skip to main content
Clinical Trials/RBR-6nxst93
RBR-6nxst93
Not yet recruiting
未知

A crossover, randomized clinical trial to evaluate the efficacy and tolerability of the meneguetti brush in self-collection of anal specimens for screening of intraepithelial lesions and sexually transmitted infections

Instituto Nacional de Infectologia Evandro Chagas - Fiocruz0 sitesFebruary 9, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Anal Cancer
Sponsor
Instituto Nacional de Infectologia Evandro Chagas - Fiocruz
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 9, 2023
End Date
December 1, 2023
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Instituto Nacional de Infectologia Evandro Chagas - Fiocruz

Eligibility Criteria

Inclusion Criteria

  • We will include participants 18 years or older, with no history of anal cancer or pelvic radiotherapy, who did not participate in Phase 1 of the study, who are being followed up for HIV or HIV prevention at the Instituto Nacional de Infectologia Evandro Chagas\-INI/Fiocruz.

Exclusion Criteria

  • Participants under the age of 18, participants who have had topical anal medication within the past 30 days or surgical treatment within the past 6 months, anal cytology performed within the past 3 months, or who have anal complaints at the time of recruitment.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical trial for evaluating validity of various acupuncture device typesNot Applicable
KCT0001347Kyung Hee University Oriental Medical Center76
Not yet recruiting
Phase 3
Comparison of the effect of an anaesthetic spray and an anaesthetic spray with additional flavouring in providing anaesthesia for nasendoscopy
ACTRN12619001493134Curtin University22
Active, not recruiting
Phase 1
Ambulatory Oxygen in Fibrotic Lung DiseaseFibrotic Lung Diseases (FLDs) are chronic and progressive conditions resulting in substantial morbidity and mortality. The cardinal symptom of all fibrotic Interstitial Lung Diseases (ILDs) is shortness of breath. Although initially present only on strenuous activities, this unfortunately progresses until even routine activities of daily living become severely limited. This has a devastating impact on Quality of Life (QOL).MedDRA version: 16.1Level: PTClassification code 10022611Term: Interstitial lung diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2013-004355-20-GBRoyal Brompton and Harefield NHS Foundation Trust
Suspended
Not Applicable
Myopia Progression and Orthokeratology Lens WearProgressing mild late-onset myopiaEye - Diseases / disorders of the eye
ACTRN12606000054516Dr Helen Owens, Senior Lecturer, Department of Optometry, University of Auckland50
Active, not recruiting
Phase 1
The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients. (EVATRAN)kidney transplantationTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
CTIS2024-513808-34-00CHRU De Nancy36